VEGFA and Ewing sarcoma: We observed that human Ewing’s sarcoma cells subjected to EWS shRNA plasmid transfection and TFL treatment failed to produce the potent angiogenic factors VEGF and b-FGF, indicating efficacy of this combination therapy in blocking angiogenesis.